Literature DB >> 20661666

Partial trisomy 11, dup(11)(q23q13), as a defect characterizing lymphomas with Burkitt pathomorphology without MYC gene rearrangement.

Barbara Pienkowska-Grela1, Grzegorz Rymkiewicz, Beata Grygalewicz, Renata Woroniecka, Paulina Krawczyk, Katarzyna Czyz-Domanska, Jan Walewski.   

Abstract

Burkitt lymphoma (BL) is an aggressive non-Hodgkin lymphoma characterized by specific morphological and immunophenotypic features. The basic genetic feature of BL is the rearrangement of MYC gene, visible as t(8;14)(q24;q32) translocation or its variant. However, some lymphomas with characteristic BL morphology are nowadays diagnosed as B-cell lymphoma unclassifiable with features intermediate between DLBCL and BL (Inter-DLBCL/BL) for biological or clinical reasons. We present four lymphomas without the MYC rearrangement presented typical Burkitt morphology, FCM immunophenotype with some deviations when compared to a typical BL. The cases were finally diagnosed as Inter-DLBCL/BL. All of them presented a recurrent abnormality within the chromosome 11: dup(11)(q23q13). We suppose that the dup(11)(q23q13), in absence of the MYC gene rearrangement, is connected with borderline lymphomas with a morphology similar or identical to that of the Burkitt lymphoma. Identifying such an aberration may be helpful in the diagnostics of Inter-DLBCL/BL eventually forming a distinct subgroup of lymphomas.

Entities:  

Mesh:

Year:  2010        PMID: 20661666     DOI: 10.1007/s12032-010-9614-0

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  15 in total

1.  Segmental tandem triplication of the MLL gene in an intravascular large B-cell lymphoma with multisystem involvement: a comprehensive morphologic, immunophenotypic, cytogenetic, and molecular cytogenetic antemortem study.

Authors:  Jeremy Deisch; Franklin Buddy Fuda; Weina Chen; Nitin Karandikar; Arnaldo A Arbini; Xin J Zhou; Huan-You Wang
Journal:  Arch Pathol Lab Med       Date:  2009-09       Impact factor: 5.534

2.  MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation.

Authors:  E Leucci; M Cocco; A Onnis; G De Falco; P van Cleef; C Bellan; A van Rijk; J Nyagol; B Byakika; S Lazzi; P Tosi; H van Krieken; L Leoncini
Journal:  J Pathol       Date:  2008-12       Impact factor: 7.996

3.  An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults.

Authors:  I T Magrath; C Janus; B K Edwards; R Spiegel; E S Jaffe; C W Berard; J Miliauskas; K Morris; R Barnwell
Journal:  Blood       Date:  1984-05       Impact factor: 22.113

Review 4.  Molecular biology of Burkitt's lymphoma.

Authors:  J L Hecht; J C Aster
Journal:  J Clin Oncol       Date:  2000-11-01       Impact factor: 44.544

5.  A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.

Authors:  Michael Hummel; Stefan Bentink; Hilmar Berger; Wolfram Klapper; Swen Wessendorf; Thomas F E Barth; Heinz-Wolfram Bernd; Sergio B Cogliatti; Judith Dierlamm; Alfred C Feller; Martin-Leo Hansmann; Eugenia Haralambieva; Lana Harder; Dirk Hasenclever; Michael Kühn; Dido Lenze; Peter Lichter; Jose Ignacio Martin-Subero; Peter Möller; Hans-Konrad Müller-Hermelink; German Ott; Reza M Parwaresch; Christiane Pott; Andreas Rosenwald; Maciej Rosolowski; Carsten Schwaenen; Benjamin Stürzenhofecker; Monika Szczepanowski; Heiko Trautmann; Hans-Heinrich Wacker; Rainer Spang; Markus Loeffler; Lorenz Trümper; Harald Stein; Reiner Siebert
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

6.  Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients.

Authors:  Catherine Patte; Anne Auperin; Mary Gerrard; Jean Michon; Ross Pinkerton; Richard Sposto; Claire Weston; Martine Raphael; Sherrie L Perkins; Keith McCarthy; Mitchell S Cairo
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

Review 7.  Burkitt lymphoma in adults.

Authors:  Archibald S Perkins; Jonathan W Friedberg
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2008

8.  Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocation.

Authors:  Deborah W Sevilla; Jerald Z Gong; Barbara K Goodman; Patrick J Buckley; Philip Rosoff; Jon P Gockerman; Anand S Lagoo
Journal:  Am J Clin Pathol       Date:  2007-12       Impact factor: 2.493

Review 9.  Adult Burkitt leukemia and lymphoma.

Authors:  Kristie A Blum; Gerard Lozanski; John C Byrd
Journal:  Blood       Date:  2004-07-20       Impact factor: 22.113

10.  Molecular analysis of structural chromosome changes affecting chromosome band 11q23.

Authors:  P R Koduru; K Offit; S C Jhanwar
Journal:  Dis Markers       Date:  1989 Jul-Sep       Impact factor: 3.434

View more
  14 in total

1.  A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma.

Authors:  Itziar Salaverria; Idoia Martin-Guerrero; Rabea Wagener; Markus Kreuz; Christian W Kohler; Julia Richter; Barbara Pienkowska-Grela; Patrick Adam; Birgit Burkhardt; Alexander Claviez; Christine Damm-Welk; Hans G Drexler; Michael Hummel; Elaine S Jaffe; Ralf Küppers; Christine Lefebvre; Jasmin Lisfeld; Markus Löffler; Roderick A F Macleod; Inga Nagel; Ilske Oschlies; Maciej Rosolowski; Robert B Russell; Grzegorz Rymkiewicz; Detlev Schindler; Matthias Schlesner; René Scholtysik; Carsten Schwaenen; Rainer Spang; Monika Szczepanowski; Lorenz Trümper; Inga Vater; Swen Wessendorf; Wolfram Klapper; Reiner Siebert
Journal:  Blood       Date:  2014-01-07       Impact factor: 22.113

2.  The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma.

Authors:  Rabea Wagener; Julian Seufert; Francesco Raimondi; Susanne Bens; Kortine Kleinheinz; Inga Nagel; Janine Altmüller; Holger Thiele; Daniel Hübschmann; Christian W Kohler; Peter Nürnberg; Rex Au-Yeung; Birgit Burkhardt; Heike Horn; Lorenzo Leoncini; Elaine S Jaffe; German Ott; Grzegorz Rymkiewicz; Matthias Schlesner; Robert B Russell; Wolfram Klapper; Reiner Siebert
Journal:  Blood       Date:  2018-12-19       Impact factor: 22.113

3.  Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain/loss pattern.

Authors:  Julio Finalet Ferreiro; Julie Morscio; Daan Dierickx; Lukas Marcelis; Gregor Verhoef; Peter Vandenberghe; Thomas Tousseyn; Iwona Wlodarska
Journal:  Haematologica       Date:  2015-03-20       Impact factor: 9.941

Review 4.  The clinicopathologic spectrum of mature aggressive B cell lymphomas.

Authors:  Lisa Rimsza; Stefania Pittaluga; Stephan Dirnhofer; Christiane Copie-Bergman; Laurence de Leval; Fabio Facchetti; Stefano Pileri; Andreas Rosenwald; Andrew Wotherspoon; Falko Fend
Journal:  Virchows Arch       Date:  2017-08-26       Impact factor: 4.064

5.  A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration.

Authors:  Grzegorz Rymkiewicz; Beata Grygalewicz; Magdalena Chechlinska; Katarzyna Blachnio; Zbigniew Bystydzienski; Joanna Romejko-Jarosinska; Renata Woroniecka; Michalina Zajdel; Katarzyna Domanska-Czyz; David Martin-Garcia; Ferran Nadeu; Pawel Swoboda; Jolanta Rygier; Barbara Pienkowska-Grela; Jan Konrad Siwicki; Monika Prochorec-Sobieszek; Itziar Salaverria; Reiner Siebert; Jan Walewski
Journal:  Mod Pathol       Date:  2018-01-12       Impact factor: 7.842

Review 6.  Molecular genetics of childhood, adolescent and young adult non-Hodgkin lymphoma.

Authors:  Rodney R Miles; Rikin K Shah; J Kimble Frazer
Journal:  Br J Haematol       Date:  2016-03-11       Impact factor: 6.998

7.  miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.

Authors:  Michalina Zajdel; Grzegorz Rymkiewicz; Magdalena Chechlinska; Katarzyna Blachnio; Barbara Pienkowska-Grela; Beata Grygalewicz; Krzysztof Goryca; Maria Cieslikowska; Zbigniew Bystydzienski; Pawel Swoboda; Jan Walewski; Jan Konrad Siwicki
Journal:  Tumour Biol       Date:  2015-02-13

8.  Burkitt-like lymphoma in a pediatric patient with familial adenomatous polyposis.

Authors:  Katie M Strobel; Jacquelyn N Crane; Kathryn L Bradford; Yalda Naeini; William A May; Vivian Y Chang
Journal:  Cancer Genet       Date:  2019-09-04

Review 9.  Virus-Driven Carcinogenesis.

Authors:  Yuichiro Hatano; Takayasu Ideta; Akihiro Hirata; Kayoko Hatano; Hiroyuki Tomita; Hideshi Okada; Masahito Shimizu; Takuji Tanaka; Akira Hara
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

10.  The 11q-Gain/Loss Aberration Occurs Recurrently in MYC-Negative Burkitt-like Lymphoma With 11q Aberration, as Well as MYC-Positive Burkitt Lymphoma and MYC-Positive High-Grade B-Cell Lymphoma, NOS.

Authors:  Beata Grygalewicz; Renata Woroniecka; Grzegorz Rymkiewicz; Jolanta Rygier; Klaudia Borkowska; Aleksandra Kotyl; Katarzyna Blachnio; Zbigniew Bystydzienski; Beata Nowakowska; Barbara Pienkowska-Grela
Journal:  Am J Clin Pathol       Date:  2017-12-20       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.